Skip to main content Accessibility help
×
Home
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2008
  • Online publication date: September 2015

21 - The impact ofcerebral small vessel disease on cognitive impairment and rehabilitation

from Section 4 - Pharmacologic and biological approaches

References

Anders, K. H., Wang, Z. Z., Kornfeld, M. et al. (1997). Giant cell arteritis in association with cerebral amyloid angio-pathy: immunohistochemical and molecular studies. Human Pathology, 28, 1237–1246.
Auerbach, I. D., Sung, S. H., Wang, Z., & Vinters, H. V. (2003). Smooth muscle cells and the pathogenesis of cerebral microvascular disease (“angiomyopathies”). Experimental and Molecular Pathology, 74, 148–159.
Barkhof, F., & Scheltens, P. (2002). Imaging of white matter lesions. Cerebrovascular Disease, 13, Suppl. 2, 21–30.
Barkhof, F., & Scheltens, P. (2006). Is the whole brain periventricular? Journal of Neurology, Neurosurgery and Psychiatry, 77, 143–144.
Bennett, D. A., Schneider, J. A., Arvanitakis, Z. et al. (2006). Neuropathology of older persons without cognitive impairment from two community based studies. Neurology, 66, 1837–1844.
Broderick, J. P. (2004). William M. Feinberg Lecture. Stroke therapy in the year 2025: burden, breakthroughs, and barriers to progress. Stroke, 35, 205–211.
Brown, W. R., Moody, D. M., Thore, C. R., & Challa, V. R. (2000). Apoptosis in leukoaraiosis. American Journal of Neuroradiology, 21, 79–82.
Burns, J. M., Church, J. A., Johnson, D. K. et al. (2005). White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease. Archives of Neurology, 62, 1870–1876.
Cadavid, D., Mena, H., Koeller, K., & Frommelt, R. R. (2000). Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies. Journal of Neuropathology and Experimental Neurology, 59, 768–773.
Carmichael, S. T. (2006). Cellular and molecular mechanisms of neural repair after stroke: making waves. Annals of Neurology, 59, 735–742.
Chui, H. (2005). Neuropathology lessons in vascular dementia. Alzheimer Disease and Associated Disorders, 19, 45–52.
Chui, H. C., Zarow, C., Mack, W. J. et al. (2006). Cognitive impact of subcortical vascular and Alzheimer’s disease pathology. Annals of Neurology, 60, 677–687.
de Groot, J. C., de Leeuw, F. E., Oudkerk, M. et al. (2002). Periventricular cerebral white matter lesions predict rate of cognitive decline. Annals of Neurology, 52, 335–341.
del Ser, T., Bermejo, F., Portera, A. et al. (1990). Vascular dementia. A clinicopathological study. Journal of the Neurological Sciences, 96, 1–17.
Dickson, D. W., Davies, P., Bevona, C. et al. (1994). Hippocampal sclerosis: a common pathological feature of dementia in very old (greater than 80 year of age) humans. Acta Neuropathologica, 88, 212–221.
Dobkin, B. (2003). The Clinical Science of Neurologic Rehabilitation. Oxford, UK: Oxford University Press.
Eng, J. A., Frosch, M. P., Choi, K., Rebeck, W. G., & Greenberg, S. M. (2004). Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Annals of Neurology, 55, 250–256.
Erkinjuntti, T., Haltia, M., Palo, J., Sulkava, R., & Paetau, A. (1988). Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study. Journal of Neurology, Neurosurgery and Psychiatry, 51, 1037–1044.
Fernando, M. S., Ince, P. G., & Group, on behalf of the MRC Cognitive Function and Ageing Neuropathology Study Group (2004). Vascular pathologies and cognition in a population-based cohort of elderly people. Journal of the Neurological Sciences, 226, 13–17.
Ferro, J. M., & Madureira, S. (2002). Age-related white matter changes and cognitive impairment. Journal of the Neurological Sciences, 203–204, 221–225.
Garde, E., Mortensen, E. L., Krabbe, K., Rostrup, E., & Larsson, H. B. (2000). Relation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal study. Lancet, 356, 628–634.
Ghiso, J., Rostagno, A., Tomidokoro, Y. et al. (2006). Genetic alterations of the BRI2 gene: familial British and Danish dementias. Brain Pathology, 16, 71–79.
Giannakopoulos, P., Gold, G., Kovari, E. et al. (2007). Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience. Acta Neuropathologica, 113, 1–12.
Gilbert, J. J., & Vinters, H. V. (1983). Cerebral amyloid angiopathy: Incidence and complications in the aging brain. I. Cerebral hemorrhage. Stroke, 14, 915–923.
Grabowski, T. J., Cho, H. S., Vonsattel, J. P. G., Rebeck, G. W., & Greenberg, S. M. (2001). Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Annals of Neurology, 49, 697–705.
Gray, F., Vinters, H. V., Le Noan, H. et al. (1990). Cerebral amyloid angiopathy and granulomatous angiitis: immunohistochemical study using antibodies to the Alzheimer A4 peptide. Human Pathology, 21, 1290–1293.
Gray, F., Robert, F., Labrecque, R. et al. (1994). Autosomal dominant arteriopathic leuko-encephalopathy and Alzheimer’s disease. Neuropathology and Applied Neurobiology, 20, 22–30.
Greenberg, S. M., Vonsattel, J. P. G., Stakes, J. W., Gruber, M., & Finklestein, S. P. (1993). The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology, 43, 2073–2079.
Hachinski, V., C., I., Petersen, R. C. et al. (2006). National Institute of Neurological Disorders and Stroke – Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards. Stroke, 37, 2220–2241.
Haglund, M., Sjobeck, M., & Englund, E. (2004). Severe cerebral amyloid angiopathy characterizes an underestimated variant of vascular dementia. Dementia and Geriatric Cognitive Disorders, 18, 132–137.
Hansen, L. A., & Crain, B. J. (1995). Making the diagnosis of mixed and non-Alzheimer dementias. Archives of Pathology and Laboratory Medicine, 119, 1023–1031.
Herzig, M. C., Van Nostrand, W. E., & Jucker, M. (2006). Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathology, 16, 40–54.
Hopkins, R. O., Beck, C. J., Burnett, D. L. et al. (2006). Prevalence of white matter hyperintensities in a young healthy population. Journal of Neuroimaging, 16, 243–251.
Hulette, C., Nochlin, D., McKeel, D. et al. (1997). Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases. Neurology, 48, 668–672.
Ince, P. G., & Fernando, M. S. (2003). Neuropathology of vascular cognitive impairment and vascular dementia. International Psychogeriatrics, 15, Suppl. 1, 71–75.
Jellinger, K. A. (2002). The pathology of ischemic-vascular dementia: an update. Journal of the Neurological Sciences, 203–204, 153–157.
Jen, J., Cohen, A. H., Yue, Q. et al. (1997). Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS). Neurology, 49, 1322–1330.
Jin, K., Wang, X., Xie, L. et al. (2006). Evidence for stroke-induced neurogenesis in the human brain. Proceedings of the National Academy of Sciences of the United States of America, 103, 13198–13202.
Kalaria, R. N., Kenny, R. A., Ballard, C. G. et al. (2004). Towards defining the neuropathological substrates of vascular dementia. Journal of the Neurological Sciences, 226, 75–80.
Kalimo, H. (2005). Pathology and Genetics. Cerebrovascular Disease. Basel, Switzerland: ISN Neuropath Press.
Kalimo, H., Ruchoux, M.-M., Viitanen, M., & Kalaria, R. N. (2002). CADASIL: a common form of hereditary arteriopathy causing brain infarcts and dementia. Brain Pathology, 12, 371–384.
Knopman, D. S., Parisi, J. E., Salviati, A. et al. (2003). Neuropathology of cognitively normal elderly. Journal of Neuropathology and Experimental Neurology, 62, 1087–1095.
Kovari, E., Gold, G., Herrmann, F. R. et al. (2004). Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke, 35, 410–414.
Lammie, G. A. (2002). Hypertensive cerebral small vessel disease and stroke. Brain Pathology, 12, 358–370.
Lim, G. T., Mendez, M. F., Bronstein, Y. L., Jouben-Steele, L., & Vinters, H. V. (2002). Clinicopathologic case report: akinetic mutism with findings of white matter hyperintensity. Journal of Neuropsychiatry and Clinical Neuroscience, 14, 214–221.
Medana, I. M., & Esiri, M. M. (2003). Axonal damage: a key predictor of outcome in human CNS diseases. Brain, 126, 515–530.
Miao, Q., Paloneva, T., Tuominen, S. et al. (2004). Fibrosis and stenosis of the long penetrating cerebral arteries: the cause of the white matter pathology in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Brain Pathology, 14, 358–364.
Munoz, D. G. (1991). The pathological basis of multi-infarct dementia. Alzheimer Disease and Associated Disorders, 5, 77–90.
Natte, R., Maat-Schieman, M. L. C., Haan, J. et al. (2001). Dementia in hereditary cerebral hemorrhage with amyloidosis – Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Annals of Neurology, 50, 765–772.
Nicoll, J. A. R., Burnett, C., Love, S. et al. (1997). High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Annals of Neurology, 41, 716–721.
Nolan, K. A., Lino, M. M., Seligmann, A. W., & Blass, J. P. (1998). Absence of vascular dementia in an autopsy series from a dementia clinic. Journal of the American Geriatrics Society, 46, 597–604.
Obici, L., Demarchi, A., de Rosa, G. et al. (2005). A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy. Annals of Neurology, 58, 639–644.
O’Brien, J. T., Erkinjuntti, T., Reisberg, B. et al. (2003). Vascular cognitive impairment. Lancet Neurology, 2, 89–98.
Ohab, J. J., Fleming, S., Blesch, A., & Carmichael, S. T. (2006). A neurovascular niche for neurogenesis after stroke. Journal of Neuroscience, 26, 13007–13016.
Palsdottir, A., Snorradottir, A. O., & Thorsteinsson, L. (2006). Hereditary cystatin C amyloid angiopathy: genetic, clini-cal, and pathological aspects. Brain Pathology, 16, 55–59.
Pantoni, L., Garcia, J. H., & Brown, G. G. (1996). Vascular pathology in three cases of progressive cognitive deterioration. Journal of the Neurological Sciences, 135, 131–139.
Prins, N. D., van Dijk, E. J., den Heijer, T. et al. (2005). Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain, 128, 2034–2041.
Rensink, A. A. M., de Waal, R. M. W., Kremer, B., & Verbeek, M. M. (2003). Pathogenesis of cerebral amyloid angio-pathy. Brain Research Reviews, 43, 207–223.
Revesz, T., Holton, J. L., Lashley, T. et al. (2002). Sporadic and familial cerebral amyloid angiopathies. Brain Pathology, 12, 343–357.
Ringelstein, E. B., & Nabavi, D. G. (2005). Cerebral small vessel diseases: cerebral microangiopathies. Current Opinion in Neurology, 18, 179–188.
Roman, G. C., Erkinjuntti, T., Wallin, A., Pantoni, L., & Chui, H. C. (2002). Subcortical ischaemic vascular dementia. Lancet Neurology, 1, 426–436.
Rosano, C., Kuller, L. H., Chung, H. et al. (2005). Subclinical brain magnetic resonance imaging abnormalities predict physical functional decline in high-functioning older adults. Journal of the American Geriatrics Society, 53, 649–654.
Rosano, C., Brach, J., Longstreth, W. T. J., & Newman, A. B. (2006). Quantitative measures of gait characteristics indicate prevalence of underlying subclinical structural brain abnormalities in high-functioning older adults. Neuroepidemiology, 26, 52–60.
Sachdev, P. S., Wen, W., Christensen, H., & Jorm, A. F. (2005). White matter hyperintensities are related to physical disability and poor motor function. Journal of Neurology, Neurosurgery and Psychiatry, 76, 362–367.
Schmidt, R., Scheltens, P., Erkinjuntti, T. et al. (2004). White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease. Neurology, 63, 139–144.
Selnes, O. A., & Vinters, H. V. (2006). Vascular cognitive impairment. Nature Clinical Practice Neurology, 2, 538–547.
Soderlund, H., Nilsson, L. G., Berger, K. et al. (2006). Cerebral changes on MRI and cognitive function: the CASCADE study. Neurobiology of Aging, 27, 16–23.
van den Heuvel, D. M., ten Dam, V. H., de Craen, A. J. et al. (2006). Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population. Journal of Neurology, Neurosurgery and Psychiatry, 77, 149–153.
Verbeek, M. M., de Waal, R. M. W., & Vinters, H. V. (2000). Cerebral Amyloid Angiopathy in Alzheimer’s Disease and Related Disorders. Dordrecht, the Netherlands: Kluwer Academic Publishers.
Vinters, H. V. (1987). Cerebral amyloid angiopathy: a criti-cal review. Stroke, 18, 311–324.
Vinters, H. V. (1992). Cerebral amyloid angiopathy and Alzheimer’s disease: two entities or one? Journal of the Neurological Sciences, 112, 1–3.
Vinters, H. V. (2001a). Cerebrovascular disease – practical issues in surgical and autopsy pathology. Current Topics in Pathology, 95, 51–99.
Vinters, H. V. (2001b). Cerebral amyloid angiopathy: a microvascular link between parenchymal and vascular dementia? Annals of Neurology, 49, 691–693.
Vinters, H. V., & Gilbert, J. J. (1983). Cerebral amyloid angio-pathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke, 14, 924–928.
Vinters, H. V., Secor, D. L., Read, S. L. et al. (1994). The microvasculature in brain biopsy specimens from patients with Alzheimer’s disease: an immunohistochemical and ultrastructural study. Ultrastructural Pathology, 18, 333–348.
Vinters, H. V., Wang, Z. Z., & Secor, D. L. (1996). Brain parenchymal and microvascular amyloid in Alzheimer’s disease. Brain Pathology, 6, 179–195.
Vinters, H. V., Farrell, M. A., Mischel, P. S., & Anders, K. H. (1998a). Basic neurobiology and cellular responses in nervous system diseases. In H. V. Vinters (Ed.), Diagnostic Neuropathology (pp. 1–49). New York, NY: Marcel Dekker Inc.
Vinters, H. V., Natte, R., Maat-Schieman, M. L. C. et al. (1998b). Secondary microvascular degeneration in amyloid angiopathy of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D). Acta Neuropathologica, 95, 235–244.
Vinters, H. V., Ellis, W. G., Zarow, C. et al. (2000). Neuropathologic substrates of ischemic vascular dementia. Journal of Neuropathology and Experimental Neurology, 59, 931–945.
Wallin, A., & Blennow, K. (1991). Pathogenetic basis of vascular dementia. Alzheimer Disease and Associated Disorders, 5, 91–102.
Wang, Z. Z., Jensson, O., Thorsteinsson, L., & Vinters, H. V. (1997). Microvascular degeneration in hereditary cystatin C amyloid angiopathy. Acta Pathologica, Microbiologica et Immunologica Scandivica, 105, 41–47.
Ylikoski, A., Erkinjuntti, T., Raininko, R., Sarna, S., Sulkava, R., & Tilvis, R. (1995). White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke, 26, 1171–1177.
Zhang-Nunes, S. X., Maat-Schieman, M. L. C., van Duinen, S. G. et al. (2006). The cerebral beta-amyloid angiopathies: hereditary and sporadic. Brain Patho-logy, 16, 30–39.